Bank of Montreal’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-62
| Closed | -$3K | – | 3594 |
|
2021
Q1 | $3K | Sell |
62
-213
| -77% | -$10.3K | ﹤0.01% | 4395 |
|
2020
Q4 | $19K | Buy |
275
+187
| +213% | +$12.9K | ﹤0.01% | 3949 |
|
2020
Q3 | $22K | Sell |
88
-2,314
| -96% | -$579K | ﹤0.01% | 3384 |
|
2020
Q2 | $474K | Sell |
2,402
-158
| -6% | -$31.2K | ﹤0.01% | 1976 |
|
2020
Q1 | $180K | Buy |
2,560
+2,427
| +1,825% | +$171K | ﹤0.01% | 2110 |
|
2019
Q4 | $9K | Hold |
133
| – | – | ﹤0.01% | 4050 |
|
2019
Q3 | $8K | Hold |
133
| – | – | ﹤0.01% | 3971 |
|
2019
Q2 | $8K | Hold |
133
| – | – | ﹤0.01% | 4111 |
|
2019
Q1 | $9K | Hold |
133
| – | – | ﹤0.01% | 3492 |
|
2018
Q4 | $7K | Hold |
133
| – | – | ﹤0.01% | 3610 |
|
2018
Q3 | $8K | Hold |
133
| – | – | ﹤0.01% | 3653 |
|
2018
Q2 | $8K | Hold |
133
| – | – | ﹤0.01% | 3670 |
|
2018
Q1 | $6K | Hold |
133
| – | – | ﹤0.01% | 3595 |
|
2017
Q4 | $8K | Buy |
+133
| New | +$8K | ﹤0.01% | 3505 |
|
2016
Q2 | – | Sell |
-67
| Closed | -$3K | – | 3774 |
|
2016
Q1 | $3K | Hold |
67
| – | – | ﹤0.01% | 3627 |
|
2015
Q4 | $3K | Hold |
67
| – | – | ﹤0.01% | 3653 |
|
2015
Q3 | $2K | Hold |
67
| – | – | ﹤0.01% | 3532 |
|
2015
Q2 | $4K | Hold |
67
| – | – | ﹤0.01% | 3424 |
|
2015
Q1 | $4K | Buy |
67
+23
| +52% | +$1.37K | ﹤0.01% | 3435 |
|
2014
Q4 | $3K | Hold |
44
| – | – | ﹤0.01% | 3373 |
|
2014
Q3 | $3K | Buy |
+44
| New | +$3K | ﹤0.01% | 3400 |
|